I have been out of XNPT for some time but had a similar thought (re Psoriasis) but I wondered why it wouldn't have shown up with Fumaderm before. I don't have the science background to know if it is a difference in compounds or not. Or could it be it was just not looked for in Psoriasis patients but with the history in MS physicians are monitoring for it more?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.